Adjunctive treatment with dexamethasone is associated with an inflammatory process reduction in the subarachnoid space [32]; it decreased the caspase-3 activation, inhibited the MMP-9 expression in the rat brains inoculated with S. pneumoniae [12], and improved neurologic outcomes in meningitis [13, 14]. Here, MMP9 is linked to meningitis.